| (USD) | Mar 2024 | Q/Q |
|---|---|---|
| Revenue | 2.6B | -2% |
| Gross Profit | 535.5MM | -6% |
| Cost Of Revenue | 2.1B | -0% |
| Operating Income | 9.7MM | -84% |
| Operating Expenses | 525.8MM | - |
| Net Income | -21.9MM | -223% |
| G&A | 477.6MM | +4% |
| Amortization | 20.3MM | -3% |
| Interest Expense | 35.7MM | -3% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
RICHMOND, Va., May 13, 2024--Owens & Minor, Inc. (NYSE: OMI), a global healthcare solutions company that provides healthcare products for home-based care, self-manufactured products, proprietary product portfolio, distribution services and innovative technology, announced today that Alex Bruni, the Company’s Executive Vice President and Chief Financial Officer and Jonathan Leon, the Company’s Senior Vice President-Finance and Corporate Treasurer, will be participating in a webcasted fireside cha
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Omnicell (OMCL) outpaces expectations in the first quarter of 2024 in a challenging customer environment.
Owens & Minor ( NYSE:OMI ) First Quarter 2024 Results Key Financial Results Revenue: US$2.61b (up 3.6% from 1Q 2023...
Owens & Minor, Inc. (NYSE:OMI) Q1 2024 Earnings Call Transcript May 3, 2024 Owens & Minor, Inc. misses on earnings expectations. Reported EPS is $ EPS, expectations were $0.17. Owens & Minor, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). […]
Despite facing operational hurdles, OMI reports a robust revenue increase and significant gross margin expansion in the first quarter.
Q1 2024 Owens & Minor Inc Earnings Call
On Friday, Owens & Minor Inc. (NYSE:OMI) reported first-quarter adjusted EPS of $0.19, up from $0.05 a year ago and beating the consensus of $0.18. Adjusted net income of $14.9 million was higher than $3.6 million a year ago. The company reported sales of $2.61 billion, up 4% Y/Y, almost in line with the consensus of $2.61 billion. Patient Direct revenue was $638 million, up 5% year over year. Products & Healthcare Services revenue was nearly $2 billion, up 3%. “Our solid performance in the firs
The headline numbers for Owens & Minor (OMI) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Comprehensive Analysis of OMI's Financial Performance and Strategic Investments